We now propose that these two molecules are promising diagnostic biomarkers profiting from the dynamic window offered by EVs, and provide a standardized protocol for use in diagnosis and in elucidating the role of the chaperone system (CS) and CTR in GBM carcinogenesis. This evidence concerns the gene CALCR and glioblastoma.